Anesthetic Considerations for Patients with Advanced Valvular Heart Disease Undergoing Noncardiac Surgery

Anesthesiology Clinics

Volumn 28, Issue 1, 2010, Pages 67-85

  Frogel, Jonathan ^a   Galusca, Dragos ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Aortic insufficiency; Aortic stenosis; Mitral insufficiency; Mitral stenosis; Noncardiac surgery; Valvular heart disease

Indexed keywords

ALCOHOL; BICARBONATE; BOTULINUM TOXIN A; CARBON MONOXIDE; COCAINE; DEXTROMETHORPHAN; FENTANYL; METHADONE; PARACETAMOL; PHTHALIC ACID DIMETHYL ESTER; POTASSIUM CHANNEL; TOXIN; VENOM; VENOM ANTISERUM;

BOTULISM; CARBON MONOXIDE INTOXICATION; CHANNELOPATHY; CHRONIC PAIN; DRUG ABUSE; DRUG INDUCED DISEASE; ECG ABNORMALITY; ENVENOMATION; EPHEDRA; HUMAN; HYPERBARIC OXYGEN; HYPERICUM PERFORATUM; INTOXICATION; JELLYFISH; LIVER TOXICITY; METABOLIC ACIDOSIS; METHEMOGLOBINEMIA; NONHUMAN; QT PROLONGATION; REVIEW; SNAKE; TERRORISM;

ANESTHESIA; AORTIC VALVE STENOSIS; HEART VALVE DISEASES; HUMANS; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; PERIOPERATIVE CARE; SURGICAL PROCEDURES, OPERATIVE;

EID: 77950819071     PISSN: 19322275     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anclin.2010.01.008     Document Type: Review

References (52)

1. Nkomo V.T., Gardin J.M., Skelton T.M., et al. Burden of valvular heart diseases: a population based study. Lancet 368 (2006) 1005-1011
2. Goldman L., Caldera D.L., Nussbaum S.R., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297 16 (1977) 845-850
3. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 50 (2007) e159-e242
4. Stewart B.F., Siscovick D., Lind B.K., et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 29 (1997) 630-634
5. Pellika P.A., Sarano M.E., Nishimura R.A., et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111 (2005) 3290-3295
6. Detsky A.S., Anrams H.B., Forbath N., et al. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med 146 (1986) 2131-2134
7. O'Keefe J.H., Shub C., and Rettke S.R. Risk of noncardiac surgical procedures in patients with aortic stenosis. Mayo Clin Proc 64 (1989) 400-405
8. Yarmush L. Noncardiac surgery in the patient with valvular heart disease. Anesthesiol Clin North America 15 (1997) 69-89
9. Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N Engl J Med 317 (1987) 91-98
10. Roberts W.C., and Ko J.M. Frequency of decades of unicuspid, bicuspid and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111 (2005) 920-925
11. Lindroos M., Kupari M., Heikkila J., et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population. J Am Coll Cardiol 21 (1993) 1220-1225
12. Carabello B.A. Aortic stenosis. N Engl J Med 346 (2002) 677-682
13. Otto C.M. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 47 (2006) 2141-2151
14. Barash P.G. Clinical anesthesia. 5th edition (2006), Lippincott Williams Wilkins, Philadelphia (PA) 898-901
15. Mittnacht A.J., Fanshawe M., and Konstadt S. Anesthetic considerations in the patient with valvular heart disease undergoing noncardiac surgery. Semin Cardiothorac Vasc Anesth 12 (2008) 33-59
16. Hess O.M., Villari B., and Krayenbuehl H.B. Diastolic dysfunction in aortic stenosis. Circulation 87 Suppl 5 (1993) 73-76
17. Torsher L., Shub C., Rettke S.R., et al. Risk of patients with severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 81 (1998) 448-452
18. Nishimura R.A., Carabello B.A., Faxon D.P., et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis. J Am Coll Cardiol 52 (2008) 676-685
19. Colard C.D., Eappen S., Lynch E.P., et al. Continuous spinal anesthesia with invasive hemodynamic monitoring for surgical repair of the hip in two patients with severe aortic stenosis. Anesth Analg 81 (1995) 195-198
20. Van Helder T., and Smedstad K.G. Combined spinal epidural anesthesia in a primigravida with valvular heart disease. Can J Anaesth 45 (1998) 488-490
21. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. J Am Soc Echocardiogr 16 (2003) 1091-1110
22. Berkeredjian R., and Grayburn P.A. Valvular heart disease: aortic regurgitation. Circulation 112 (2005) 125-134
23. Carabello B.A., and Crawford F.A. Valvular heart disease. N Engl J Med 337 (1997) 32-41
24. Stoelting R. Anesthesia and co-existing disease. 4th edition (2002), Churchill Livingstone Elsevier, Philadelphia (PA) p. 38-42
25. Padmavati S. Rheumatic fever and rheumatic heart disease in India at the turn of the century. Indian Heart J 53 (2001) 35-37
26. Golbasi Z., Ucar O., Keles T., et al. Increased levels of high sensitivity C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail 4 (2002) 593-595
27. Chandrashekhar Y., Westaby S., and Narula J. Mitral stenosis. Lancet 374 (2009) 1271-1283
28. Vincelj J., Sokol I., and Jaksic O. Prevalence and clinical significance of left atrial spontaneous echo contrast detected by transesophageal echocardiography. Echocardiography 19 (2002) 319-324
29. Gash A.K., Carabello B.A., Cepin D., et al. Left ventricular ejection performance and systolic muscle function in patients with mitral stenosis. Circulation 67 (1983) 148-154
30. Diker E., Aydogdu S., Ozdemir M., et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol 77 (1997) 96-98
31. Augoustides J.G., Culp K., and Smith S. Rebound pulmonary hypertension and cardiogenic shock after withdrawal of inhaled prostacyclin. Anesthesiology 100 (2004) 1023-1025
32. Miller O.I., Tang S.F., Keech A., et al. Rebound pulmonary hypertension on withdrawal of inhaled nitric oxide. Lancet 346 (1995) 51-52
33. Pan P.H., and D'Angelo R. Anesthetic and analgesic management of mitral stenosis during pregnancy. Reg Anesth Pain Med 29 (2004) 610-615
34. Holocker T.T., Wedel D.J., Benzon H., et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 28 (2003) 172-197
35. Tayama E., Ueda T., Shojima T., et al. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg 6 (2007) 715-719
36. Mahoney P.D., Loh E., Blitz L.R., et al. Hemodynamic effects of inhaled nitric oxide in women with mitral stenosis and pulmonary hypertension. Am J Cardiol 87 (2001) 188-192
37. Sacan O., White P.F., Tufanogullari B., et al. Sugammadex reversal of rocuronium induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edophonium-atropine. Anesth Analg 104 (2007) 569-574
38. Fagan C., Frizelle H.P., Laffey J., et al. The effects of intracuff lidocaine on endotracheal tube induced emergence phenomena after general anesthesia. Anesth Analg 91 (2000) 201-205
39. Klein A., Burstow D., Tajik A., et al. Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr 3 (1990) 54-63
40. Olson L., Subramanian R., Ackerman D., et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc 62 (1987) 22-34
41. Marwick T.H., Lancelloti P., and Pierard L. Ischemic mitral regurgitation: mechanisms and diagnosis. Heart 95 (2009) 1711-1718
42. Lawrie G.M. Mitral valve repair vs replacement. Current recommendations and long-term results. Cardiol Clin 16 (1998) 437-448
43. Enriquez-Sarano M., Akins C.W., and Vahanian A. Mitral regurgitation. Lancet 373 (2009) 1382-1394
44. Carabello B.A. The current therapy for mitral regurgitation. J Am Coll Cardiol 52 (2009) 319-326
45. Gillinov A.M. Ablation of atrial fibrillation with mitral valve surgery. Curr Opin Cardiol 20 (2005) 107-114
46. Comfere T., Sprung J., Kumar M.M., et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 100 (2005) 636-644
47. Mayer J., Boldt J., Poland R., et al. Continuous arterial pressure waveform based cardiac output using the FloTrac/Vigileo: a review and meta analysis. J Cardiothorac Vasc Anesth 23 (2009) 401-406
48. Schober P., Loer S.A., and Schwarte L.A. Perioperative hemodynamic monitoring with transesophageal Doppler technology. Anesth Analg 109 (2009) 340-353
49. Siu S.C., Kowalchuk G.J., Welty F.K., et al. Intra-aortic balloon counterpulsation supporting the high-risk cardiac patient undergoing urgent non-cardiac surgery. Chest 99 (1991) 1342-1345
50. Jett G.K., Picone A.L., and Clark R.E. Circulatory support for right ventricular dysfunction. J Thorac Cardiovasc Surg 94 (1987) 95-103
51. Healy D.G., Veerasingam D., McHale J., et al. Successful perioperative utilization of inhaled nitric oxide in mitral valve surgery. J Cardiovasc Surg 47 (2006) 217-220
52. Lai H.C., Lee W.L., Wang K.Y., et al. Mitral regurgitation complicates postoperative outcome of noncardiac surgery. Am Heart J 153 (2007) 712-717